Bavarian Nordic, mpox vaccine
Bavarian says mpox vaccine approved by EU regulator for adolescents
Bavarian Nordic said on Thursday its mpox vaccine was approved by the EU's drug regulator for use in adolescents, bolstering the case for using the shot in the 12 to 17 age group to contain an outbreak in parts of Africa.
Bavarian Gets EU Approval for Mpox Vaccine for Adolescents
Bavarian Nordic A/S, one of the only companies with a vaccine approved for mpox, has received regulatory approval in Europe for the use of its jab for adolescents.
Pharmalittle: We’re reading about Bavarian Nordic’s mpox shot, a crackdown on Ozempic prescribing and more
Anthem Blue Cross Blue Shield is taking an unusually hard line on doctors who it says improperly prescribed Ozempic.
EU drug regulator approves Bavarian's mpox vaccine for adolescents, company says
The EU's drug regulator has approved Bavarian Nordic's mpox vaccine for use in adolescents aged 12 to 17 years, the company said on Thursday, bolstering evidence for using the shot in that age group to contain an outbreak in parts of Africa.
EU Approves Use of Bavarian Nordic's Mpox Vaccine for Adolescents
Bavarian Nordic's mpox vaccine has gained approval for use in adolescents by the EU's drug regulator. This move is seen as essential for containing an outbreak in parts of Africa, with the World Health Organization declaring mpox a global public health emergency.
EU approves Bavarian Nordic's mpox vaccine for adolescents
Mpox, declared a global public health emergency by WHO, has disproportionately affected children and adolescents
Gavi to buy 500,000 mpox vaccine doses from Bavarian Nordic
The global vaccine group Gavi will buy 500,000 doses of Bavarian Nordic's mpox vaccine, its first purchase of the shot to help battle an outbreak in parts of Africa, the group said on Wednesday.
Bavarian Nordic Gets EMA Approval Of Mpox Vaccine For Adolescents
(RTTNews) - Bavarian Nordic A/S (BAVA) Thursday said that the European Commission has adopted the Committee for Medicinal Products for Human Use (CHMP) recommendation for the approval of a type II variation for IMVANEX smallpox and mpox vaccine. This extends the current marketing authorization to include adolescents 12 to 17 years of age.
EU extends authorization of the mpox vaccine to adolescents
The European Commission on Friday extended the authorization of the Imvanex mpox vaccine to teenagers aged 12 to 17. "Although the overall risk of being infected with mpox for the general EU population remains low,
WHO clears Bavarian Nordic's vaccine for mpox, sets up access scheme
The World Health Organization and partners on Friday set up a scheme to help bring mpox vaccines, tests and treatments to the ...
Bavarian Gets Order for Half a Million Mpox Shots for Africa
Gavi, the Vaccine Alliance, is purchasing 500,000 mpox vaccines from Bavarian Nordic A/S for African countries hardest-hit by ...
shorenewsnetwork10h
Mountain Creek Oktoberfest to Bring Bavarian Fun to Vernon
On September 21 and 22, Mountain Creek’s Red Tail Lodge will come alive with Bavarian spirit as it hosts Oktoberfest from 12 ...
UK Secures Additional Doses Of Bavarian Nordic Mpox Vaccine To Combat New Variant Threat
The U.K. government has secured over 150,000 doses of the mpox vaccine from Bavarian Nordic A/S (OTC:BVNRY) (OTC:BVNKF) to ...
MLive2d
‘Mad Bavarian’ revels in consistency/boredom for Saginaw-area football predictions
Hugh “The Mad Bavarian” Bernreuter revels in his consistency. But instead of applauding, the Madman’s fans – both of them – ...